SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-011001
Filing Date
2014-03-04
Accepted
2014-03-04 17:41:21
Documents
1
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7672
  Complete submission text file 0001140361-14-011001.txt   9293
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 364 LOMBARD ST. SAN FRANCISCO CA 94133
Business Address
Maderis Gail J (Reporting) CIK: 0001503147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 14666378